[Classification and therapy of vasculitis according to recommendations of the European League Against Rheumatism (EULAR)].
Vasculitis is still being classified according the criteria of the American College of Rheumatology and the Chapel Hill Consensus Conference Definitions. Diagnostic criteria are currently being established. The classification criteria are based on the size of the inflamed blood vessel (e.g. large vessel vasculitis with inflammation of the aorta and its branches), clinical symptoms and findings (such as cephalalgia in giant cell arteritis) and histological findings. In recent years a definition of disease stages and activity has been established and a number of controlled trials have been carried out in order to provide evidence-based stage and activity adapted therapy regimens. Recommendations for the management of vasculitis have been published in 2009 by EULAR (European League Against Rheumatism). This article gives a review of the classification of vasculitis and summarizes the current European guidelines on management.
Holle
J U
JU
Klinik für Rheumatologie und Klinische Immunologie, Klinikum Bad Bramstedt, Oskar-Alexander-Str. 26, 24576, Bad Bramstedt, Deutschland. holle@klinikumbb.de
Bley
T
T
Gross
W L
WL
D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D015267:Churg-Strauss Syndrome / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D005060:Europe; D019317:Evidence-Based Medicine; D014890:Granulomatosis with Polyangiitis / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D055953:Microscopic Polyangiitis / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D010641:Phenotype; D056647:Systemic Vasculitis / Q000145:classification / Q000175:diagnosis / Q000628:therapy*